AMSTERDAM, November 2, 2011 /PRNewswire/ --
Elsevier, the world-leading publisher of scientific, technical and medical information products and services, announced today that its 2012 eBook Frontlist collections are available for advance purchase on SciVerse ScienceDirect, Elsevier's online platform for scientific content. This release marks a significant increase in the breadth and depth of the eBook collection on SciVerse ScienceDirect. The 2012 collection covers 23 distinct subject areas, with individual titles scheduled to publish between January 1 and December 31, 2012.
This year sees an increase in the number of Science and Technology (S&T) titles, with more than 50% growth strategically delivered in each of the following top selling collections: Biochemistry, Genetics and Molecular Biology, Biomedical Science and Medicine, Chemistry and Pharmacology, Toxicology and Pharmaceutical Science. The chemistry collection alone has doubled in size while the Health Sciences (HS) Clinical Medicine collection has increased by 14%. These are all high quality titles, selected for relevance and published under imprints including Academic Press, Pergamon, North-Holland, W.B. Saunders, Mosby and Churchill Livingstone.
"Our strategic aim for books on SciVerse ScienceDirect is to grow our collections in the subjects our customers want and need most, while retaining our rigorous publication and peer review process to ensure high quality, " said Suzanne BeDell, Managing Director, Elsevier Science and Technology Books. "By combining Elsevier's trusted content with the benefits of accessibility to books, journals, and innovative mobile applications on the Sciverse ScienceDirect platform, today's academic, government and corporate institutions are empowered to accelerate research."
Some of the new eBook titles for SciVerse ScienceDirect include:
Librarians, researchers, and those interested in the eBooks 2012 Collections, or any previously published eBooks can visit http://www.info.sciverse.com/sciencedirect/content/books/lbi
Join our Community:
About SciVerse ScienceDirect
SciVerse ScienceDirect (http://www.sciverse.com) contains over a quarter of the world's full text scientific, technical and medical (STM) peer-reviewed articles - managed by renowned editors, written by respected authors and read by researchers from around the globe. Elsevier's extensive full-text collection covers authoritative titles from the core scientific literature with more than ten million articles available online. Coverage includes over 2,500 journal titles published by Elsevier with dynamic linking to journals from approximately 2,000 STM publishers through CrossRef. Additionally, SciVerse ScienceDirect contains an expanding library of online major reference works, handbooks, book series and over 10,000 eBooks in all fields of science seamlessly interlinked with primary research referenced in journal articles.
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Nursing Consult, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Senior Manager, Corporate Relations, Elsevier
Copyright©2010 PR Newswire.
All rights reserved